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Abstract
Background: The fate of gold nanoparticles, 2, 40 and 100 nm, administered intratracheally to
adult female mice was examined. The nanoparticles were traced by autometallography (AMG) at
both ultrastructural and light microscopic levels. Also, the gold content was quantified by
inductively coupled plasma mass spectrometry (ICP-MS) and neutron activation analysis (NAA).
The liver is the major site of deposition of circulating gold nanoparticles. Therefore the degree of
translocation was determined by the hepatic deposition of gold. Mice were instilled with 5
intratracheal doses of gold nanoparticles distributed over a period of 3 weeks and were killed 24
h after the last dose. One group of mice were given a single intratracheal dose and were killed after
1 h.
Results: The instilled nanoparticles were found in lung macrophages already 1 h after a single
instillation. In mice instilled treated repeatedly during 3 weeks, the load was substantial.
Ultrastructurally, AMG silver enhanced gold nanoparticles were found in lysosome-/endosome-like
organelles of the macrophages and analysis with AMG, ICP-MS and NAA of the liver revealed an
almost total lack of translocation of nanoparticles. In mice given repeated instillations of 2 nm gold
nanoparticles, 1.4‰ (by ICP-MS) to 1.9‰ (by NAA) of the instilled gold was detected in the liver.
With the 40 nm gold, no gold was detected in the liver (detection level 2 ng, 0.1‰) except for one
mouse in which 3‰ of the instilled gold was found in the liver. No gold was detected in any liver
of mice instilled with 100 nm gold (detection level 2 ng, 0.1‰) except in a single animal with 0.39‰
of the dose in the liver.
Conclusion: We found that that: (1) inert gold nanoparticles, administered intratracheally are
phagocytosed by lung macrophages; (2) only a tiny fraction of the gold particles is translocated into
systemic circulation. (3) The translocation rate was greatest with the 2 nm gold particles.
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Epidemiological studies have reported associations
between episodes of increased air pollution with particu-
late matter and adverse health effects in susceptible indi-
viduals [1-6]. It has been suggested, that the nanosized
particles are the most dangerous fraction [7]. Air-borne
nanoparticles (ultrafine particles) have been found to
penetrate into the systemic circulation following inhala-
tion [8,9]. Additionally, there is experimental evidence
that respiratory exposure to nanoparticles may promote
thrombosis [10,11]. It has been suggested that lung injury
increases the degree of the nanoparticle translocation
[12]. For a better understanding of the potential hazards
of inhaled nanoparticles it is important to establish
whether nanoparticles are translocated, i.e. transported
through the alveolar barrier to the systemic circulation. It
is known, that nanoparticles, once in the lungs, can be rec-
ognized and phagocytosed by lung macrophages [13]. The
degree of translocation seems to be dependent on particle
size, chemical composition, shape, electrical charge etc
[14]. Smaller particles have been shown to more easily
penetrate through the alveolar barrier than larger ones
[14,15]. Once in the systemic circulation, the nanoparti-
cles can reach extrapulmonary organs like liver, spleen, etc
[8,9,16]. Translocation of inhaled ultrafine particles into
the brain via the olfactory system has also been reported
[16-18].
As a model we chose gold nanoparticles which are consid-
ered nontoxic [19] and can be traced histochemically by
AMG, even ultrastructurally. Such gold nanoparticles are
already in use for diagnostics, therapy and research [20-
24]. Takenaka and coworkers treated rats with an aerosol
of gold nanoparticles, 5-8 nm in diameter, produced by a
spark generator. They observed accumulation of such par-
ticles in the pulmonary macrophages and epithelial cells
and a low degree of systemic translocation [25]. Semmler-
Behnke and coworkers demonstrated that intratracheally
instilled 18 nm gold nanoparticles are retained in the rat
lungs whereas 1.4 nm nanoparticles are being translo-
cated in significant amounts to the secondary organs [26].
We hypothesized that 40 and 100 nm gold nanoparticles
would be retained in lung macrophages and translocated
to a minor degree while according to present ideas; 2 nm
particles would be translocated and subsequently accu-
mulate in the liver. We have previously reported that 40
nm colloidal gold nanoparticles are easily detected in liver
after intravenous injection [27] and that the liver accumu-
lates and retains most of the dose for a long period of time
[28]. We therefore assume that if gold nanoparticles are
translocated through alveolar epithelium they will be
accumulated primarily in the liver.
The objective of the present study was to evaluate the
extent of gold nanoparticle translocation from the lungs
into the systemic circulation. As a model for evaluation of
whether nanoparticles penetrate lung epithelium we
instilled gold nanoparticles, sized 2, 40 and 100 nm in
mice intratracheally, and examined the lungs and the liver
by optical and electron microscopy. We wanted to estab-
lish the significance of size in translocation and to identify
where and in which cells the nanoparticles accumulated
using LM and EM autometallography (AMG). AMG ena-
bles tracing of gold nanoparticles in morphologically
intact tissue by silver enhancement of the individual nan-
oparticles [20,29]. To add the quantitative dimension the
tissues were further analyzed by ICP-MS and neutron acti-
vation (NAA).
Experimental
Gold nanoparticles
Gold nanoparticles from Fitzgerald Industries Inc, USA
had been produced by citrate reduction. They were nega-
tively charged, monodisperse and spherical. The 2 nm
contained 15 × 1013 particles/ml (12.1 μg), the 40 nm 9 ×
1010/ml (58.2 μg) and the 100 nm 6 × 109/ml (60.1 μg).
The animal model
The study was performed in accordance with Danish law
and guidelines for animal welfare. A total of 44 adult
female C57BL mice were used. The mice were 8-12 weeks
old with a body of weight of 18-21 grams. The mice were
housed in plastic cages under the following conditions: 12
h light/dark cycle, 22 +/- 2°C and 50 +/- 10% relative
humidity. Food (Altromin No. 1314, Altromin Spezialfut-
terwerke, Germany) and tap water were available ad libi-
tum.
Single instillations
Eight mice were divided into 3 experimental groups and 1
control group, 2 mice in each. Two mice were instilled
intratracheally with 50 μl 2, 40 or 40 nm gold nanoparti-
cles and were killed after 1 h. Two control mice were
instilled with distilled water and treated identically. These
8 animals were used for histochemical analysis with the
AMG method. In adition, 4 mice were used to NAA anal-
ysis. Two of them were given 50 μl 40 nm gold nanopar-
ticles and the other 2 were instilled with distilled water
and served as controls. These animals were sacrificed after
1 day and analyzed with NAA.
Repeated instillations
Twenty mice were divided into 3 experimental groups and
1 control group, 5 mice in each. Five mice were given 50
μl of a 2 nm gold suspension, similarly 5 mice were given
40 nm gold and 5 mice 100 nm gold. The 5 mice served as
controls and were exposed to distilled water only. These
20 mice were intratracheally instilled 5 times during a
period of 3 weeks and sacrificed 24 hours after the last
instillation. Tissues from these 20 mice were used both forPage 2 of 7
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sis with the ICP-MS method. In a second experiment 12
mice were used to NAA analysis. Six mice were given 2 nm
gold nanoparticles and the other 6 animals served as con-
trols. The livers of these animals were analyzed with NAA.
The neutron activation dose was greater in this experiment
resulting in a lower detection level (see NNA section).
Transcardial perfusion
The mice were anesthetized with sodium pentobarbital
(50 mg/kg body weight) and transcardially perfused at
120 mm Hg with 3% buffered glutaraldehyde for 5 min (1
min of rapid flow followed by 4 min of reduced flow 5-10
ml/min). The lungs and liver were taken out immediately
after perfusion and placed in the 3% buffered glutaralde-
hyde solution. In the "repeated instillations" groups, the
median lobe of the liver was used for histological analysis.
The lobe was divided at the gall bladder bifurcature. The
right part of the lobe was used for paraffin sections
whereas the left part was used for Epon sections and elec-
tron microscopy. The animals that were used for quantita-
tive analysis with neutron activation were sacrificed by
cervical dislocation and were not transcardialy perfused.
Tissue processing
The tissue selected for paraffin sectioning was dehydrated
and paraffin embedded. The tissue was then cut into 8 μm
thick sections. In all mice the same part of the liver was
used for paraffin embedding, i.e., the right part of the
median lobe, divided at the gall bladder bifurcature. This
block of the liver measures approximately 10 × 5 × 5 mm.
Seven to ten sections were cut from each mouse organ.
The sectioning was performed with random start, and
every 125th section was selected for analysis. These ran-
domly selected sections were then AMG developed for 60
min and counterstained with toluidine blue. Tissue to be
embedded in Epon blocks was cut in approximately 2 × 2
× 2 mm blocks with a razorblade or scalpel and rinsed in
0.10 M phosphate buffer (pH 7.4) for 2 × 5 min, then
dehydrated in graded ethanol solutions and embedded in
Epon. Semithin sections (3 μm) were cut with an ultrami-
crotome (Leica EM UC6, Leica Microsystems GmbH, Ger-
many) and placed on glass slides before being AMG
developed. After light microscopic analyses, selected sec-
tions were re-embedded on top of a blank Epon block and
trimmed to include only the regions of interest. Thereaf-
ter, ultrathin sections were cut and counterstained with
lead citrate and uranyl acetate before electron microscopic
analysis on a Philips Morgagni 268D, FEI, USA.
AMG development
The AMG developer consisted of a 60 ml gum arabic solu-
tion and 10 ml sodium citrate buffer (25.5 g of citric
acid·1H2O + 23.5 g sodium citrate·2H20 to 100 ml dis-
tilled water). Immediately before use 15 ml reducing
agent (0.85 g of hydroquinone dissolved in 15 ml distilled
water at 40°C) and 15 ml of a solution containing silver
ions (0.12 g silver lactate in 15 ml distilled water at 40°C)
were added, and the AMG developer was thoroughly
stirred [28]. The glass slides were put in a jar filled with the
AMG developer and placed in a water bath at 26°C. Dur-
ing AMG development an electric device shook the jars
gently. The entire set-up was covered with a dark hood
while the developing took place. After 60 minutes the
AMG development was stopped by rinsing the slices in
water and afterwards replacing the developer with a 5%
sodium thiosulphate solution for 10 min (the AMG stop
bath solution). The jars were then placed under gently
running water for 20 minutes.
Post AMG treatment
The sections from the different sources were counter-
stained with a 0.1% aqueous toluidine blue solution (pH
4.0), dehydrated in alcohol to xylene, and ultimately
embedded in DEPEX and covered with a cover glass.
Black/brown silver grains represented silver-encapsulated
gold nanoparticles. All procedures and protocols have
previously been described in details [28].
Inductively coupled plasma mass spectroscopy (ICP-MS)
The median lobe, comprising about one third of the liver
mass in mice, was used for morphological observations
while the ICP-MS analysis was performed on the remain-
ing part of the liver. Water was purified by reverse osmosis
(Elix 100, Millipore, Bedford, MA, USA) and a Milli-Q sys-
tem (Millipore). Polystyrene test tubes (Sarstedt, Numbre-
cht, Germany) were washed in tenfold diluted nitric acid
(65% analytical grade; Merck, Darmstadt, Germany) and
stored containing 0.7 M nitric acid purified by sub-boiling
distillation in quartz still (Heraeus, Hanau, Germany).
Digestion vessels were cleaned before use by adding 7.5
ml hydrochloric acid (30% p.a. plus, Fluka, Buchs, Swit-
zerland) and 2.5 ml nitric acid and performing a wash
cycle in the microwave oven (Mars 5, CEM Corporation,
Matthews, NC, USA) at 300 W for 30 min.
Each sample was transferred to a freshly cleaned and
rinsed microwave digestion vessel. Then 5 ml of sub-boil-
ing distilled nitric acid and 0.5 ml hydrogen peroxide
(30% p.a., Riedel-de-Haen, Seelze, Germany) was added,
and the samples were digested for 60 min at 600 W. After
cooling the vessels were opened, 1 ml hydrochloric acid
was added to each vessel, and a further 10 min digestion
at 600 W was carried out. Upon cooling the clear digest
was transferred to a polystyrene test tube and diluted to 10
ml with high purity water. Prior to analysis the digests,
sample preparation blanks, and calibrants were diluted
appropriately and thallium was added to a concentration
of 25 μg/l as internal standard. A certified gold standard
solution from Ultra Scientific (Kingstown, RI, USA) wasPage 3 of 7
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the diluted sample digests were carried out using induc-
tively coupled plasma - sector field mass spectrometry
(Element, Thermo Scientific, Bremen, Germany). The
ICP-MS analysis was performed by ALS Scandinavia AB,
Luleå, Sweden.
Neutron activation analysis
Neutron activation analysis (NAA) was performed at the
Nuclear Research Reactor of the Helmholtz Center Berlin,
Germany. The liver samples were freeze-dried and irradi-
ated in an O-ring sealed test tube at a reproducibly achiev-
able position within the reactor tank. For calibration
purposes a pre-weighed gold standard was irradiated at
the same location for the same time; from its measured
radioactivity the Au mass in the liver samples was ana-
lyzed. For validation of the NAA method different
amounts of gold was added to livers of untreated mice. In
the first experiment the detection limit was 3.9 ng. In the
second experiment the samples were irradiated with a
greater dose of neutrons for obtaining a lower detection
limit. The slope of the regression line of added versus
detected gold was 1.013 and the detection limit was about
1 ng gold.
Results
Autometallographic analysis
Single instillations
In all 6 mice instilled intratracheally with a single dose of
2, 40 or 100 nm gold nanoparticles, gold was detected in
the macrophages of the lungs after 1 h. Ultrastructurally,
the nanoparticles were located inside lysosome-like vesi-
cles. AMG stained sections from control animals were all
void of gold (Fig. 1C).
Repeated instillations
20 animals were instilled intratracheally with gold nano-
particles 5 times during a period of 3 weeks. Initially, there
were 4 groups consisting of 5 animals in each. These ani-
mals were exposed to 2, 40, 100 nm gold nanoparticles
and distilled water, respectively. However, only 16 ani-
mals survived the experiment: 3 animals exposed to 2 nm
gold nanoparticles and 1 animal exposed to 40 nm parti-
cles died during the instillation. All the animals exposed
to 100 nm gold nanoparticles or distilled water only sur-
vived. The distribution of gold in the lungs of the animals
treated by multiple instillations was identical to the pat-
tern seen in the single instillation group although the
AMG staining intensity and the amount of loaded cells
were higher. Nanoparticles of all three sizes were retained
in the lungs (Fig. 1A, B, D, E). The instilled gold nanopar-
ticles were located in lysosome-like organelles in lung
macrophages (Fig. 1D, E). The nanoparticles were present
in macrophages, both those attached to the alveolar wall
and inside the interstitium. However, we could not deter-
mine, whether the nanoparticles were located only in the
macrophages or both in the macrophages and epithelial
cells. Careful microscopic analysis of randomly selected
cryosections of the liver revealed no sign of gold nanopar-
ticles in the exposed animals. Only in one animal,
exposed to multiple instillations of 40 nm gold nanopar-
ticles, AMG enhanced gold nanoparticles were seen in a
few Kupffer cells.
Quantitative analysis with Inductively Coupled Plasma 
Mass Spectrometry
The livers of mice treated with multiple instillations were
analyzed with ICP-MS (Table 1). The two mice that sur-
vived 5 instillations with 2 nm particles showed traces of
gold in the liver, 4 and 4.1 ng gold in each. The total gold
mass which was given to these 2 mice during a period of
3 weeks was 3025 ng of pure gold per animal and the
amount of gold traced in the liver was 1.32 and 1.36‰ of
the total dose given. In 1 animal, receiving 40 nm parti-
cles, 43.4 ng of gold was detected in the liver which is 3‰
of the total 14550 ng gold given. The amount of gold in
the liver of the remaining three 40 nm gold mice was
below detection level. In 1 animal, exposed to 100 nm
particles, 5.8 ng of gold was traced in the liver which is
0.39‰ of the total 15 μ gold given. In the remaining 4
mice, given 100 nm gold nanoparticles, the amount of
gold in the liver was below the detection limit. No gold
was detected in all 5 control mice treated with distilled
water.
Neutron activation analysis (NAA)
Two mice of the four mice included in the NAA study were
instilled with a dose 2.9 μg 40 nm gold nanoparticles. No
gold was detected in the liver, neither in the experimental
animals nor in the controls. The detection limit was 3.9
ng, which is < 2‰ of the instilled amount of gold. In the
second experiment 6 mice were instilled intratracheally
with 2 nm gold and 6 mice were instilled with distilled
water to examine whether the gold instillations were toxic
and to quantify the gold with greater sensitivity. The neu-
tron activation dose was greater in this experiment result-
ing in a lower detection level, i.e. 1 ng. All 6 mice were
unaffected by the gold instillations with the 2 nm gold.
One day after the 5th instillation the gold content was
determined only by NAA. The livers of the mice contained
5.8 ± 1.8 ng (mean ± standard deviation). Because the
mice were instilled with an accumulated dose of 3.03 μg
gold, 1.9 ± 0.6‰ of the instilled 2 nm gold particles had
accumulated in the liver 1 day after the 5th injection.
Discussion
When nanoparticles are inhaled and deposited in the lung
a fraction of them are being phagocytozed by alveolar
macrophages [13]. A part of the particles are removed
from the lung by the mucociliary escalator, but a part isPage 4 of 7
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Light and electron micrographs showing AMG enhanced gold nanoparticles in the lungs of mice following intratracheal instilla-tionsFi ure 1
Light and electron micrographs showing AMG enhanced gold nanoparticles in the lungs of mice following 
intratracheal instillations. A and B represent LM section taken from the animals exposed to multiple intratracheal instilla-
tions with gold, 40 nm and 100 nm nanoparticles, respectively. AMG enhanced gold nanoaparticles are located inside lung mac-
rophages resembling cells. C represents a control, void of AMG staining. D and E are EM picture representing the animals 
exposed to multiples instillations with 40 nm gold nanoparticles. Gold is located inside lysosome/endosome-like vesicles. Scale-
bars: 20 μm in A - C; 1 μm in D; 500 nm in E.
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Translocation of nanoparticles through the alveolar bar-
rier, if it takes place, has been speculated to depend prima-
rily on endocytotic-exocytotic activity and less so by
paracellular transport e.g., due to histamine, hydrogen
peroxide [13].
We detected 1.32-1.36‰ of the instilled dose of 2 nm
gold in the liver by ICP-MS and 1.9 ± 0.6‰ by NAA in the
second experiment. In 4 mice instilled 40 nm and 4 mice
instilled 100 nm gold particles the liver was completely
void of gold. However, in the fifth mouse of the 40 nm
nanoparticles group gold was detected in the liver by both
ICP-MS and by AMG. The gold content of the liver of that
particular mouse was very high, which suggests airway
damage during the instillation and an uptake of gold nan-
oparticles though the damaged tissue. One mouse in the
100 nm group had 0.39‰ accumulation of the gold dose
in the liver. This is probably also due to damage to the air-
ways during the installation.
Our study supports that only small amounts of gold nan-
oparticles are translocated from lungs [24,25] However,
Semmler-Behnke reported significant translocation of
smaller (1.4 nm) gold nanoparticles to the liver (0.7%).
Similarily, we found that translocation of 2 nm particles
takes place (only 1.3-1.9‰). However, another group
reported significant systemic translocation following
inhalation of gold nanoparticles with average diameter of
20 nm. Yu and coworkers detected 4.84% of the lung con-
centration in the blood 15 days after exposure [16]. The
discrepancy between Yu and coworker's findings and ours
could be caused by differences in the surface characteris-
tics of the gold nanoparticles used. It should be noticed,
however, that they used rats, not mice, in their study. Also
they exposed animals via inhalation, not instillation.
We found that gold could be traced in macrophages in the
lungs in all 6 mice 1 hour after they were instilled intrat-
racheally with a single dose of 50 μl gold nanoparticles.
This proves that the uptake of gold into the lysosome-like
organelles of macrophages is a rapid process. To establish
the degree of systemic translocation, the livers of the ani-
mals were analyzed with AMG and ICP-MS. We have pre-
viously found that the liver is the main organ for
accumulation of gold nanoparticles, and it is therefore a
good probe for the translocation rate [18]. Our data sug-
gest that very small amounts of gold particles 2 nm or less
in size are translocated in normal healthy lungs and
whereas there is less translocation of 40 nm and the 100
nm gold.
The present study shows that: (1) intratracheally instilled
colloidal gold nanoparticles are being phagocytized by
macrophages of the lungs; (2) translocation of the intrat-
racheally instilled gold nanoparticles to systemic circula-
tion is below detection limits of the used techniques or
very low. (3) The translocation of 2 nm gold nanoparticles
is greater than of 40 and 100 nm ones.
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